Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Tax Withholding of 1,733 TRDA shares, $12.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 1,733 | $12.4K |
| Apr 2, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 2,500 | $32.4K |
| Mar 11, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 5,089 | $66.2K |
| Mar 6, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 7,988 | $97.9K |
| Mar 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 44,600 | n/a |
| Nov 24, 2025 | Entrada Therapeutics, Inc. (TRDA) | Sale | 8,910 | $88.9K |
| Sep 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 1,734 | $9.4K |
| Apr 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Exercise/Conversion | 11,134 | $23.4K |
| Mar 19, 2025 | Entrada Therapeutics, Inc. (TRDA) | Sale | 1,784 | $19.0K |
| Mar 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 42,400 | n/a |